NO20076662L - Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff - Google Patents

Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Info

Publication number
NO20076662L
NO20076662L NO20076662A NO20076662A NO20076662L NO 20076662 L NO20076662 L NO 20076662L NO 20076662 A NO20076662 A NO 20076662A NO 20076662 A NO20076662 A NO 20076662A NO 20076662 L NO20076662 L NO 20076662L
Authority
NO
Norway
Prior art keywords
therapeutic antibody
malantigen
absence
independent
detection
Prior art date
Application number
NO20076662A
Other languages
English (en)
Norwegian (no)
Inventor
Helmut Lenz
Werner Scheuer
Martina Thier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20076662L publication Critical patent/NO20076662L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20076662A 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff NO20076662L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05014618 2005-07-06
EP06004447 2006-03-06
PCT/EP2006/006524 WO2007003420A1 (fr) 2005-07-06 2006-07-05 Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant

Publications (1)

Publication Number Publication Date
NO20076662L true NO20076662L (no) 2008-04-03

Family

ID=36922121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076662A NO20076662L (no) 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Country Status (19)

Country Link
US (1) US20070009976A1 (fr)
EP (2) EP2194380A3 (fr)
JP (1) JP2008545145A (fr)
KR (1) KR20080016939A (fr)
AR (1) AR053948A1 (fr)
AU (1) AU2006265275A1 (fr)
BR (1) BRPI0612591A2 (fr)
CA (1) CA2613187A1 (fr)
CR (1) CR9635A (fr)
EC (1) ECSP088081A (fr)
IL (1) IL188317A0 (fr)
MA (1) MA29730B1 (fr)
MX (1) MX2008000277A (fr)
MY (1) MY157955A (fr)
NO (1) NO20076662L (fr)
NZ (1) NZ564471A (fr)
RU (1) RU2008103608A (fr)
TW (1) TWI312864B (fr)
WO (1) WO2007003420A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1282443E (pt) * 2000-05-19 2009-12-04 Genentech Inc Análise de detecção génica para melhorar a probabilidade de uma resposta eficaz a uma terapia do cancro com um antagonista de erbb
KR20110050567A (ko) 2004-07-22 2011-05-13 제넨테크, 인크. Ｈｅｒ２ 항체 조성물
KR101134208B1 (ko) 2004-10-01 2012-04-09 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 촬상 장치 및 그 방법
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
DK1850874T3 (da) 2005-02-23 2013-11-11 Genentech Inc Forlængelse af tid til sygdomsprogression eller overlevelse for ovariecancer ved anvendelse af pertuzumab
PE20070207A1 (es) * 2005-07-22 2007-03-09 Genentech Inc Tratamiento combinado de los tumores que expresan el her
US8358354B2 (en) 2009-01-26 2013-01-22 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical abberations
WO2007092581A2 (fr) 2006-02-07 2007-08-16 The Board Of Trustees Of The Leland Stanford Junior University Procédé de correction d'aberrations optiques
BRPI0808418A2 (pt) 2007-03-02 2014-07-22 Genentech, Inc Predição de resposta a um inibidor de her
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
MY194408A (en) 2011-10-14 2022-11-30 Genentech Inc Uses for and Article of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab
KR101327542B1 (ko) * 2012-03-15 2013-11-08 광주과학기술원 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법
AU2012232949B2 (en) * 2012-09-28 2014-07-03 Willowtree Holdings Pty Ltd Temporary bulkhead
TWI554284B (zh) 2013-04-16 2016-10-21 建南德克公司 帕妥珠單抗（ｐｅｒｔｕｚｕｍａｂ）變體及其評估
RU2020120593A (ru) 2014-04-25 2020-09-01 Дженентек, Инк. Способы лечения раннего рака молочной железы трастузумабом-mcc-dm1 и пертузумабом
WO2016196373A2 (fr) 2015-05-30 2016-12-08 Genentech, Inc. Procédés de traitement de cancer du sein métastatique her2 positif
WO2017087280A1 (fr) 2015-11-16 2017-05-26 Genentech, Inc. Procédés de traitement d'un cancer positif her2
JP6914336B2 (ja) 2016-12-28 2021-08-04 ジェネンテック， インコーポレイテッド 進行したｈｅｒ２発現がんの治療
CN117752782A (zh) 2017-01-17 2024-03-26 豪夫迈·罗氏有限公司 皮下her2抗体配制剂
CN116531511A (zh) 2017-03-02 2023-08-04 豪夫迈·罗氏有限公司 Her2阳性乳腺癌的辅助治疗
CN110536969A (zh) 2017-04-24 2019-12-03 豪夫迈·罗氏有限公司 跨膜或近膜域中的erbb2/her2突变
KR20250151568A (ko) 2020-06-29 2025-10-21 제넨테크, 인크. 퍼투주맙 + 트라스투주맙 고정 용량 조합

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0940468A1 (fr) * 1991-06-14 1999-09-08 Genentech, Inc. Domaine variable d'un anticorps humanisé
WO1993021319A1 (fr) 1992-04-08 1993-10-28 Cetus Oncology Corporation ANTICORPS HUMANISES SPECIFIES PAR C-erbB-2
CA2269204C (fr) 1996-10-18 2012-01-24 Genentech, Inc. Anticorps anti-erbb2
ATE443259T1 (de) 2001-09-20 2009-10-15 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
EP2263691B1 (fr) * 2002-07-15 2012-08-29 F.Hoffmann-La Roche Ag Traitement de cancer avec l'anti-erbb2 anticorps recombinant humanisé monoclonal (rhuMAb 2C4)

Also Published As

Publication number Publication date
MA29730B1 (fr) 2008-09-01
CR9635A (es) 2008-02-20
EP2194380A3 (fr) 2010-07-14
BRPI0612591A2 (pt) 2010-11-23
RU2008103608A (ru) 2009-08-20
TWI312864B (en) 2009-08-01
ECSP088081A (es) 2008-02-20
MY157955A (en) 2016-08-30
AU2006265275A1 (en) 2007-01-11
EP2194380A2 (fr) 2010-06-09
JP2008545145A (ja) 2008-12-11
US20070009976A1 (en) 2007-01-11
EP1902315A1 (fr) 2008-03-26
MX2008000277A (es) 2008-03-24
AR053948A1 (es) 2007-05-23
KR20080016939A (ko) 2008-02-22
WO2007003420A1 (fr) 2007-01-11
NZ564471A (en) 2010-04-30
CA2613187A1 (fr) 2007-01-11
TW200741203A (en) 2007-11-01
IL188317A0 (en) 2008-04-13

Similar Documents

Publication Publication Date Title
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
MX2009013411A (es) Deteccion de antigenos transportados por eritrocitos y de anticuerpos anti-eritrocitos.
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
BRPI0809138B8 (pt) método para detectar a presença ou quantidade de um ou mais analitos em uma amostra biológica
WO2008070229A3 (fr) Détection d'agrégats pathogènes de protéine dans un échantillon par elisa homologue
NZ609824A (en) Immunochromatography devices, methods and kits
WO2013074520A3 (fr) Détection, isolement et analyse de cellules rares dans des liquides biologiques
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
NZ609363A (en) Methods for determining anti-drug antibody isotypes
FR2935384B1 (fr) Procede de detection du virus de la rougeole, dispositif et kit utilisant ce procede
BRPI0906060A2 (pt) anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
WO2010096674A3 (fr) Dosages de biomarqueur a+
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
WO2008073895A3 (fr) Procédés et dispositifs d'analyse de la salive
MX2014010068A (es) Metodos y sistemas para amplificacion de señal de bioensayos.
WO2006069023A3 (fr) Procede et appareil d'analyse avec effets de matrices d'echantillons reduits
WO2011008831A3 (fr) Marqueurs de masse pour l'analyse spectrométrique d'immunoglobulines
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2009111572A3 (fr) Cellule, procédé et kit de réalisation d'un essai de neutralisation d'anticorps
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2011003598A3 (fr) Détection d'antigènes
WO2007024735A3 (fr) Methode et anticorps destines a detecter le nitrofurane
MX2008000282A (es) Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa.
GB201119585D0 (en) Assay
WO2006099537A3 (fr) Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application